Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Alnylam Pharmaceuticals stopped treating patients with its experimental drug fitusiran following the death of a clinical trial participant, according to Reuters.
Florida residents should refill prescription medications before Hurricane Irma hits the state, even if their current supply seems like an adequate amount, according to Candy McGuyre, corporate marketing director of Pensacola, Fla.-based Baptist Health Care.
Eli Lilly and Co. will lay off about 8 percent of its employees to cut costs in 2018, reports Reuters.
Novo Nordisk will pay nearly $58.7 million to settle a civil lawsuit claiming the company's sales team failed to share accurate information about health risks associated with the diabetes drug Victoza.
Flu season is coming and healthcare providers must prepare for its impact, according to Marie Fournier, director of business development and marketing for Montreal, Canada-based TECSYS.
The Food and Drug Administration placed a clinical hold on two of Collectis' clinical trials for an immunotherapy drug after a patient's death, reports Genetic Engineering & Biotechnology News.
Hospira recalled one lot of Hydromorphone, a pain medication, and four lots of the blood pressure drug Levophed Thursday due to a potential lack of sterility assurance.
Here are six drugmakers that made headlines in the past week.
Novartis, a Swiss pharmaceutical company, named its Global Head of Drug Development and CMO Vasant Narasimhan, MD, successor to current CEO Joe Jimenez, who will step down Jan. 31.
Teleflex, a medical device maker, will purchase NeoTract, a urology device manufacturer, for up to $1.1 billion, according to Reuters.